Jiangsu Hengrui Medicine
600276.SS
#463
Rank
โ‚น3.756 T
Marketcap
โ‚น588.91
Share price
-1.68%
Change (1 day)
15.52%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

EPS for Jiangsu Hengrui Medicine (600276.SS)

EPS in 2023 (TTM): โ‚น7.46

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is โ‚น7.76. In 2022 the company made an earnings per share (EPS) of โ‚น7.74 a decrease over its 2021 EPS that were of โ‚น9.33.

EPS history for Jiangsu Hengrui Medicine from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น7.46-3.61%
2022โ‚น7.74-17.1%
2021โ‚น9.33-24.44%
2020โ‚น12.3520.3%
2019โ‚น10.2725.58%
2018โ‚น8.1827.55%
2017โ‚น6.4121.64%
2016โ‚น5.2713.57%
2015โ‚น4.6439.86%
2014โ‚น3.3221.33%
2013โ‚น2.7317.7%
2012โ‚น2.3225.56%
2011โ‚น1.8526.22%
2010โ‚น1.4710.3%
2009โ‚น1.3357.92%
2008โ‚น0.8411.06%
2007โ‚น0.7685.81%
2006โ‚น0.4187.94%
2005โ‚น0.2233.97%
2004โ‚น0.1629.78%
2003โ‚น0.1219.78%
2002โ‚น0.10